Action VIVE VIVEVE MEDICAL, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Viveve Medical, Inc.

Actions

VIVE

US92852W5013

Marché Fermé - OTC Markets
Autres places de cotation
 20:20:42 26/04/2024 		Varia. 5j. Varia. 1 janv.
0,0002 USD -33,33% Graphique intraday de Viveve Medical, Inc. -33,33% -.--%
2023 InMode Ltd. (NasdaqGS:INMD) a acquis les actifs de propriété intellectuelle de Viveve Medical Inc. CI
2023 Mise à jour sectorielle : Les actions du secteur de la santé terminent près des planchers intrajournaliers MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index
VIVEVE MEDICAL, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows
Sector Update: Health Care Stocks Sputtering in Tuesday Trading
Top Midday Decliners
Sector Update: Health Care
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday
Sector Update: Health Care
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday
Top Premarket Decliners
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq
Viveve Medical : Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence - Form 8-K
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
VIVEVE MEDICAL, INC. : Costs Associated with Exit or Disposal Activities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)
Viveve Medical to Seek Strategic Alternatives
VIVEVE MEDICAL, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action VIVE
  4. Actualités Viveve Medical, Inc.
  5. Autres langues